BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miao M, De Clercq E, Li G. Clinical significance of chemokine receptor antagonists. Expert Opin Drug Metab Toxicol 2020;16:11-30. [PMID: 31903790 DOI: 10.1080/17425255.2020.1711884] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 27.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu D, He H, Kong F, Cao Y, Zang F, Ma M, Gu N, Zhang Y. A versatile metal–organic nanoplatform in combination with CXCR4 antagonist and PD-L1 inhibitor for multimodal synergistic cancer therapy and MRI-guided tumor imaging. Nano Today 2022;47:101689. [DOI: 10.1016/j.nantod.2022.101689] [Reference Citation Analysis]
2 Yang J, Zhu Q, Wu Y, Qu X, Liu H, Jiang B, Ge D, Song X. Utilization of macrocyclic peptides to target protein-protein interactions in cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.992171] [Reference Citation Analysis]
3 Wu X, Qian L, Zhao H, Lei W, Liu Y, Xu X, Li J, Yang Z, Wang D, Zhang Y, Zhang Y, Tang R, Yang Y, Tian Y. CXCL12/CXCR4: an amazing challenge and opportunity in the fight against fibrosis. Ageing Research Reviews 2022. [DOI: 10.1016/j.arr.2022.101809] [Reference Citation Analysis]
4 Wu Y, Yang Z, Cheng K, Bi H, Chen J. Small molecule-based immunomodulators for cancer therapy. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.11.007] [Reference Citation Analysis]
5 Tapmeier TT, Howell JH, Zhao L, Papiez BW, Schnabel JA, Muschel RJ, Gal A. Evolving polarisation of infiltrating and alveolar macrophages in the lung during metastatic progression of melanoma suggests CCR1 as a therapeutic target. Oncogene 2022. [PMID: 36241867 DOI: 10.1038/s41388-022-02488-3] [Reference Citation Analysis]
6 Deng K, Lin S, Xu Z, Qin J, Yuan L, Sun Y, Wei J, Zheng T, Zheng Z, Qin F, Li S. A novel gene signature derived from the CXC subfamily of chemokine receptors predicts the prognosis and immune infiltration of patients with lung adenocarcinoma. Medicine 2022;101:e30982. [DOI: 10.1097/md.0000000000030982] [Reference Citation Analysis]
7 Zhang H, Yang K, Chen F, Liu Q, Ni J, Cao W, Hua Y, He F, Liu Z, Li L, Fan G. Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications. Front Immunol 2022;13:975367. [DOI: 10.3389/fimmu.2022.975367] [Reference Citation Analysis]
8 Offringa R, Kötzner L, Huck B, Urbahns K. The expanding role for small molecules in immuno-oncology. Nat Rev Drug Discov 2022. [PMID: 35982333 DOI: 10.1038/s41573-022-00538-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Sibiya T, Ghazi T, Chuturgoon A. The Potential of Spirulina platensis to Ameliorate the Adverse Effects of Highly Active Antiretroviral Therapy (HAART). Nutrients 2022;14:3076. [PMID: 35893930 DOI: 10.3390/nu14153076] [Reference Citation Analysis]
10 Landoni G, Zangrillo A, Piersanti G, Scquizzato T, Piemonti L. The effect of reparixin on survival in patients at high risk for in-hospital mortality: a meta-analysis of randomized trials. Front Immunol 2022;13:932251. [DOI: 10.3389/fimmu.2022.932251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li Z, Yu S, Jiang Y, Fu Y. Chemokines and chemokine receptors in allergic rhinitis: from mediators to potential therapeutic targets. Eur Arch Otorhinolaryngol 2022. [PMID: 35732904 DOI: 10.1007/s00405-022-07485-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ahmed RA, Adekoya KO, Onwuamah CK, Oboh BO, Iyer SS, Oluwatosin AS, Audu RA, Ezechi OC. Mechanism of Viral Suppression among HIV Elite Controllers and Long-Term Nonprogressors in Nigeria and South Africa. Viruses 2022;14:1270. [PMID: 35746741 DOI: 10.3390/v14061270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Hunter P, Payne-dwyer AL, Shaw M, Signoret N, Leake MC. Single-molecule and super-resolved imaging deciphers membrane behaviour of onco-immunogenic CCR5.. [DOI: 10.1101/2022.05.19.492692] [Reference Citation Analysis]
14 Shao Z, Tan Y, Shen Q, Hou L, Yao B, Qin J, Xu P, Mao C, Chen L, Zhang H, Shen D, Zhang C, Li W, Du X, Li F, Chen Z, Jiang Y, Xu HE, Ying S, Ma H, Zhang Y, Shen H. Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3. Cell Discov 2022;8. [DOI: 10.1038/s41421-022-00403-4] [Reference Citation Analysis]
15 Ibrahim SRM, Choudhry H, Asseri AH, Elfaky MA, Mohamed SGA, Mohamed GA. Stachybotrys chartarum—A Hidden Treasure: Secondary Metabolites, Bioactivities, and Biotechnological Relevance. JoF 2022;8:504. [DOI: 10.3390/jof8050504] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Gilchrist A, Echeverria SL. Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma. Front Endocrinol (Lausanne) 2022;13:846310. [PMID: 35399952 DOI: 10.3389/fendo.2022.846310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Eberle SA, Gustavsson M. A Scintillation Proximity Assay for Real-Time Kinetic Analysis of Chemokine–Chemokine Receptor Interactions. Cells 2022;11:1317. [DOI: 10.3390/cells11081317] [Reference Citation Analysis]
18 Li G, Wang Y, De Clercq E. Approved HIV reverse transcriptase inhibitors in the past decade. Acta Pharmaceutica Sinica B 2022;12:1567-90. [DOI: 10.1016/j.apsb.2021.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
19 Bush K, Wairkar Y, Tang S. Nucleoside reverse transcriptase inhibitors are the major class of HIV antiretroviral therapeutics that induce neuropathic pain in mice.. [DOI: 10.1101/2022.01.27.478061] [Reference Citation Analysis]
20 Langdon K, Buitrago G, Pickering D, Giacomin P, Loukas A, Haleagrahara N. Na-AIP-1 secreted by human hookworms suppresses collagen-induced arthritis. Inflammopharmacology 2022. [PMID: 35031905 DOI: 10.1007/s10787-021-00909-5] [Reference Citation Analysis]
21 Propper DJ, Balkwill FR. Harnessing cytokines and chemokines for cancer therapy. Nat Rev Clin Oncol 2022. [PMID: 34997230 DOI: 10.1038/s41571-021-00588-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 52] [Article Influence: 42.0] [Reference Citation Analysis]
22 Liu M, Yang J, Xu B, Zhang X. Tumor metastasis: Mechanistic insights and therapeutic interventions. MedComm (2020) 2021;2:587-617. [PMID: 34977870 DOI: 10.1002/mco2.100] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
23 Elemam NM, Khalil BA, Maghazachi AA. Chemokines and Chemokine Receptors. Encyclopedia of Infection and Immunity 2022. [DOI: 10.1016/b978-0-12-818731-9.00061-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Dulal D, Boring AR, Terrero D, Tiwari AK, Raman D. Shaping of the Immune Landscape by Chemokine Receptors that Impacts the Clinical Outcome in Triple-Negative Breast Cancer. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_20] [Reference Citation Analysis]
25 Kulmann-Leal B, Ellwanger JH, Chies JAB. CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population. Front Immunol 2021;12:758358. [PMID: 34956188 DOI: 10.3389/fimmu.2021.758358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Matsuo K, Yoshie O, Nakayama T. Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity. Cancers (Basel) 2021;13:6132. [PMID: 34885241 DOI: 10.3390/cancers13236132] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
27 Sprague DJ, Getschman AE, Fenske TG, Volkman BF, Smith BC. Trisubstituted 1,3,5-Triazines: The First Ligands of the sY12-Binding Pocket on Chemokine CXCL12. ACS Med Chem Lett 2021;12:1773-82. [PMID: 34795867 DOI: 10.1021/acsmedchemlett.1c00388] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Zeng Z, Lan T, Wei Y, Wei X. CCL5/CCR5 axis in human diseases and related treatments. Genes Dis 2021. [PMID: 34514075 DOI: 10.1016/j.gendis.2021.08.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
29 Tammam SN, El Safy S, Ramadan S, Arjune S, Krakor E, Mathur S. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2. J Control Release 2021;337:258-84. [PMID: 34293319 DOI: 10.1016/j.jconrel.2021.07.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
30 DeSantis AJ, Enten GA, Gao X, Majetschak M. Chemokine receptor antagonists with α1-adrenergic receptor blocker activity. J Basic Clin Physiol Pharmacol 2021. [PMID: 34144642 DOI: 10.1515/jbcpp-2020-0523] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Ding Y, Li G, Zhou Z, Deng T. Molecular mechanisms underlying hepatitis C virus infection-related diabetes. Metabolism 2021;121:154802. [PMID: 34090869 DOI: 10.1016/j.metabol.2021.154802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Cao XY, Qian X, Liu GD, Wang YH. Bioinformatics-based Identification of Key Pathways and Hub Genes of Traumatic Brain Injury in a Rat Model. Curr Med Sci 2021;41:610-7. [PMID: 34047944 DOI: 10.1007/s11596-021-2365-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Zhang R, Miao T, Qin M, Zhao C, Wang W, Zhang C, Liu X, Chen Y, Chen A, Wang Y. CX3CL1 Recruits NK Cells Into the Central Nervous System and Aggravates Brain Injury of Mice Caused by Angiostrongylus cantonensis Infection. Front Cell Infect Microbiol 2021;11:672720. [PMID: 34017692 DOI: 10.3389/fcimb.2021.672720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Miao M, Clercq E, Li G. Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective. Biomedicines 2021;9:412. [PMID: 33920487 DOI: 10.3390/biomedicines9040412] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
35 Karuppusamy KV, Babu P, Thangavel S. The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV. Stem Cell Rev Rep 2021. [PMID: 33788143 DOI: 10.1007/s12015-021-10145-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Rodríguez‐fernández JL, Criado‐garcía O. Chemoattraction: Basic Concepts and Role in the Immune Response. eLS 2021. [DOI: 10.1002/9780470015902.a0029241] [Reference Citation Analysis]
37 Lingappa JR, Lingappa VR, Reed JC. Addressing Antiretroviral Drug Resistance with Host-Targeting Drugs-First Steps towards Developing a Host-Targeting HIV-1 Assembly Inhibitor. Viruses 2021;13:451. [PMID: 33802145 DOI: 10.3390/v13030451] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
38 Schrijver B, Assmann JLJC, van Gammeren AJ, Vermeulen RCH, Portengen L, Heukels P, Langerak AW, Dik WA, van der Velden VHJ, Ermens TAAM. Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcome. Eur Cytokine Netw 2020;31:154-67. [PMID: 33648924 DOI: 10.1684/ecn.2020.0456] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
39 Trotta AM, Aurilio M, D'Alterio C, Ieranò C, Di Martino D, Barbieri A, Luciano A, Gaballo P, Santagata S, Portella L, Tomassi S, Marinelli L, Sementa D, Novellino E, Lastoria S, Scala S, Schottelius M, Di Maro S. Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors. J Med Chem 2021;64:3449-61. [PMID: 33660512 DOI: 10.1021/acs.jmedchem.1c00066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
40 Li G, Xu M, Yue T, Gu W, Tan L. Life-long passion for antiviral research and drug development: 80th birthday of Prof. Dr. Erik De Clercq. Biochem Pharmacol 2021;185:114485. [PMID: 33617841 DOI: 10.1016/j.bcp.2021.114485] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
41 Li G, Yue T, Zhang P, Gu W, Gao LJ, Tan L. Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday. Molecules 2021;26:923. [PMID: 33572409 DOI: 10.3390/molecules26040923] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
42 Kudo-Saito C, Ozaki Y, Imazeki H, Hayashi H, Masuda J, Ozawa H, Ogiwara Y. Targeting Oncoimmune Drivers of Cancer Metastasis. Cancers (Basel) 2021;13:554. [PMID: 33535613 DOI: 10.3390/cancers13030554] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
43 Kichloo A, Albosta M, Kumar A, Aljadah M, Mohamed M, El-Amir Z, Wani F, Jamal S, Singh J, Kichloo A. Emerging therapeutics in the management of COVID-19. World J Virol 2021; 10(1): 1-29 [PMID: 33585175 DOI: 10.5501/wjv.v10.i1.1] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
44 Sordillo PP, Sordillo LA. Glioblastoma cell-induced immunosuppression causing chemoresistance. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies 2021. [DOI: 10.1016/b978-0-12-821567-8.00008-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
45 Wen B, Zhang C, Zhou J, Zhang Z, Che Q, Cao H, Bai Y, Guo J, Su Z. Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways. Pharmacol Ther 2021;222:107752. [PMID: 33253739 DOI: 10.1016/j.pharmthera.2020.107752] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
46 Eiger DS, Boldizsar N, Honeycutt CC, Gardner J, Rajagopal S. Biased agonism at chemokine receptors. Cell Signal 2021;78:109862. [PMID: 33249087 DOI: 10.1016/j.cellsig.2020.109862] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
47 Prator CA, Donatelli J, Henrich TJ. From Berlin to London: HIV-1 Reservoir Reduction Following Stem Cell Transplantation. Curr HIV/AIDS Rep 2020;17:385-93. [PMID: 32519184 DOI: 10.1007/s11904-020-00505-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
48 Li Y, Xiao Y, Chen Y, Huang K. Nano-based approaches in the development of antiviral agents and vaccines. Life Sci 2021;265:118761. [PMID: 33189824 DOI: 10.1016/j.lfs.2020.118761] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
49 Yeregui E, Viladés C, Domingo P, Ceausu A, Pacheco YM, Veloso S, Inciarte A, Vidal-González J, Peraire M, Perpiñán C, Falcó V, Masip J, Alba V, Vargas M, Martí A, Reverté L, Mallolas J, Vidal F, Peraire J, Rull A. High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients. EBioMedicine 2020;62:103077. [PMID: 33166788 DOI: 10.1016/j.ebiom.2020.103077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
50 Dhaiban S, Al-Ani M, Elemam NM, Maghazachi AA. Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. J Inflamm Res 2020;13:619-33. [PMID: 33061527 DOI: 10.2147/JIR.S270872] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
51 Wang Y, Li Y, Jia D, Zheng J, Wang G. Correlation between single nucleotide polymorphisms in CXCR4 microRNA binding site and the susceptibility to knee osteoarthritis in Han Chinese population. J Clin Lab Anal 2021;35:e23600. [PMID: 32978834 DOI: 10.1002/jcla.23600] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
52 Sanfilippo C, Castrogiovanni P, Imbesi R, Nunnari G, Di Rosa M. Postsynaptic damage and microglial activation in AD patients could be linked CXCR4/CXCL12 expression levels. Brain Res 2020;1749:147127. [PMID: 32949560 DOI: 10.1016/j.brainres.2020.147127] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
53 Kaur S, Bansal R, Kollimuttathuillam S, Gowda AM, Singh B, Mehta D, Maroules M. The looming storm: Blood and cytokines in COVID-19. Blood Rev 2021;46:100743. [PMID: 32829962 DOI: 10.1016/j.blre.2020.100743] [Cited by in Crossref: 40] [Cited by in F6Publishing: 47] [Article Influence: 20.0] [Reference Citation Analysis]
54 Jiang B, Liu T, Gao Y. Chemokines in chronic pain: cellular and molecular mechanisms and therapeutic potential. Pharmacology & Therapeutics 2020;212:107581. [DOI: 10.1016/j.pharmthera.2020.107581] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 27.0] [Reference Citation Analysis]
55 Fakhouri EW, Peterson SJ, Kothari J, Alex R, Shapiro JI, Abraham NG. Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm. Antioxidants (Basel) 2020;9:E636. [PMID: 32708430 DOI: 10.3390/antiox9070636] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
56 Aldinucci D, Borghese C, Casagrande N. The CCL5/CCR5 Axis in Cancer Progression. Cancers (Basel) 2020;12:E1765. [PMID: 32630699 DOI: 10.3390/cancers12071765] [Cited by in Crossref: 98] [Cited by in F6Publishing: 103] [Article Influence: 49.0] [Reference Citation Analysis]
57 Malone RW, Tisdall P, Fremont-Smith P, Liu Y, Huang XP, White KM, Miorin L, Olmo EMD, Alon A, Delaforge E, Hennecker CD, Wang G, Pottel J, Smith N, Hall JM, Shapiro G, Mittermaier A, Kruse AC, García-Sastre A, Roth BL, Glasspool-Malone J, Ricke DO. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Res Sq 2020:rs. [PMID: 32702719 DOI: 10.21203/rs.3.rs-30934/v2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
58 Scala S, D'Alterio C, Milanesi S, Castagna A, Carriero R, Farina FM, Locati M, Borroni EM. New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM. Vaccines (Basel) 2020;8:E164. [PMID: 32260318 DOI: 10.3390/vaccines8020164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
59 Chintagunta AD, Kumar M, Sampath Kumar NS, Jeevan Kumar SP. Differential Diagnosis and Possible Therapeutics for Coronavirus Disease 2019. Medical Virology: From Pathogenesis to Disease Control 2020. [DOI: 10.1007/978-981-15-6006-4_4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]